Beneficient Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Year	2022	2022	2021	2020
Cash & Equivalents	9.55	0.32	20.32	17.88
Cash & Cash Equivalents	9.55	0.32	20.32	17.88
Cash Growth	2850.31%	-98.41%	13.66%	-
Other Current Assets	-	0.23	-18.76	-17.87
Total Current Assets	-	0.55	1.56	0.01
Long-Term Investments	-	212.03	210.11	0
Goodwill and Intangibles	2,371	0	2,371	2,371
Other Long-Term Assets	-	0	-2,370.85	-2,370.93
Total Long-Term Assets	-	212.03	210.11	0.11
Total Assets	2,911	212.58	3,184	2,816
Accounts Payable	65.72	0.58	58.43	17.84
Other Current Liabilities	-	0.06	-58.17	-17.74
Total Current Liabilities	-	0.64	0.26	0.1
Other Long-Term Liabilities	-	8.78	16.46	0
Total Long-Term Liabilities	-	8.78	16.46	0
Total Liabilities	231.79	9.42	181.37	282.84
Total Debt	151.44	0	112.08	256.34
Debt Growth	-	-	-56.28%	-
Retained Earnings	0	-8.71	-15.16	-0
Comprehensive Income	9.9	0	-1.44	0
Shareholders' Equity	1,586	-8.71	755.32	621.5
Net Cash / Debt	-141.9	0.32	-91.76	-238.46
Net Cash Per Share	-168.21	0.99	-142.44	-416.46
Working Capital	-	-0.09	1.3	-0.09
Book Value Per Share	1880.33	-26.77	1172.53	1085.41

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).